The convergence of CNS and oncology research amplifies the significance of Oncotelic’s recent intellectual property updates for OT-101. Developed in collaboration with Sapu Bioscience, the expanded ...

The health ministry’s traditional medicine is developing a national research and technology network for Persian medicine to integrate scientific and technological efforts to enhance Persian medicine’s ...

TuHURA Biosciences, Inc. ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that it has filed ...

A phase 1/2 study with open-label, dose escalation phase followed by single-arm expansion at the maximum tolerated dose to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and ...

Ready for a master's that makes a difference? Miami University's Advanced Inquiry Program (AIP) is an innovative online degree, integrating flexible courses with unparalleled experiential learning at ...

Pharmacodynamics (PD) is an area of pharmacology concerned with the relationship between a drug’s concentration at the site of action and the resulting effect, and to measurement of that relationship ...

Most courses in the department fall into one or more of the following categories. Please choose the appropriate category and then the appropriate course, where you will find some or all of the ...

Enterprises that seek to become proficient in advanced manufacturing must incorporate manufacturing management tools and integrate data throughout the supply chain. This course makes participants ...

CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key ...

About Advanced Micro Devices Inc. Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and ...

Biosimilar natalizumab (Tyruko) is approved by EMA, US FDA, MHRA etc. and article is intended only for the HCP audience in ...